Optimal surgical strategy for hepatocellular carcinoma with portal vein tumor thrombus: a prospective randomized controlled trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800020119

Enrollment

Unknown

Registered

2018-12-15

Start date

2018-12-31

Completion date

Unknown

Last updated

2018-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

1:Partial hepatectomy and peeling off

2:Partial hepatectomy and en bloc resection

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. hepatocellular carcinoma; 2. liver function Child-Pugh grade A; 3. tumor thrombus located in one side of the liver lobe, the extent of involvement according to Cheng's tumor thrombus classification criteria for type I-IIa; 4. preoperative imaging assessment of primary cancer lesions and Portal vein tumor thrombus has resectability; 5. no distant metastasis, liver dysfunction, other organ dysfunction and other surgical contraindications.

Exclusion criteria

Exclusion criteria: ?Subjects were reluctant to continue to withdraw from the clinical study; ? Subjects were poorly compliant and did not follow the study procedure; ? were lost to follow-up.

Design outcomes

Primary

Measure	Time frame
Overall survival;Disease-free survival;	—

Secondary

Measure	Time frame
Adverse Event;Postoperative recurrence rate;Type of postoperative recurrence;	—

Countries

China

Contacts

Public ContactLu Wang

Fudan University Cancer Center

fuscczyf@163.com+86 17802148816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026